SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury

RecruitingOBSERVATIONAL
Enrollment

411

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 30, 2025

Conditions
End Stage Liver DiseaseJaundiceLiver DysfunctionPortal Hypertension
Interventions
DEVICE

FibroScan® Expert 630

The SSM by FibroScan 630 was first performed after admission, repeated at the day 5±2 as soon as feasible, and finally evaluated before discharge.

Trial Locations (1)

510515

RECRUITING

Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER